Patents by Inventor Daniel Pflaster

Daniel Pflaster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250367363
    Abstract: Described herein are method and kits for locally treating or preventing infection in a patient in need thereof. The method may include locally administering to a human patient a plurality of doses of at least one antiseptic agent in solution by irrigating the at least one antiseptic agent at a wound, wherein the administration provides the patient continuous localized antiseptic therapy for at least a 24-hour period, at least 48-hour period, at least a 72-hour period, or at least a 96-hour period.
    Type: Application
    Filed: August 13, 2025
    Publication date: December 4, 2025
    Applicant: Osteal Therapeutics, Inc.
    Inventors: Brian C. DE BEAUBIEN, Kevin WARNER, Jude PAGANELLI, William C. PUTNAM, Daniel PFLASTER
  • Publication number: 20250268717
    Abstract: Provided herein are rapid and effective local infection therapy methods, systems, and devices that significantly reduce the mortality, morbidity, and the cost of care in rare musculoskeletal infections. Continuous delivery of antibiotic therapy locally, at the infection site, reduces edema and provides antibiotic irrigation, significantly improving outcomes while reducing the need for systemic antibiotics.
    Type: Application
    Filed: January 31, 2025
    Publication date: August 28, 2025
    Inventors: Brian de Beaubien, Jude Paganelli, Daniel Pflaster, Daivon Deans, Ryan Watson, Brian Bowman
  • Publication number: 20250241900
    Abstract: Described herein are method and kits for locally treating or preventing fungal infection in a patient in need thereof. The method may include locally administering to a human patient a plurality of doses of at least one antifungal agent in solution by irrigating the at least one antifungal agent at a wound, wherein the administration provides the patient continuous localized antifungal therapy for at least a 24-hour period, at least 48-hour period, at least a 72-hour period, or at least a 96-hour period.
    Type: Application
    Filed: March 7, 2025
    Publication date: July 31, 2025
    Applicant: Osteal Therapeutics, Inc.
    Inventors: Brian C. DE BEAUBIEN, Kevin WARNER, Jude PAGANELLI, Willam C. PUTNAM, Daniel PFLASTER
  • Patent number: 12239538
    Abstract: Provided herein are rapid and effective local infection therapy methods, systems, and devices that significantly reduce the mortality, morbidity, and the cost of care in rare musculoskeletal infections. Continuous delivery of antibiotic therapy locally, at the infection site, reduces edema and provides antibiotic irrigation, significantly improving outcomes while reducing the need for systemic antibiotics.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: March 4, 2025
    Assignee: Osteal Therapeutics, Inc.
    Inventors: Brian de Beaubien, Jude Paganelli, Daniel Pflaster, Daivon Deans, Ryan Watson, Brian Bowman
  • Publication number: 20220047392
    Abstract: Provided herein are rapid and effective local infection therapy methods, systems, and devices that significantly reduce the mortality, morbidity, and the cost of care in rare musculoskeletal infections. Continuous delivery of antibiotic therapy locally, at the infection site, reduces edema and provides antibiotic irrigation, significantly improving outcomes while reducing the need for systemic antibiotics.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 17, 2022
    Inventors: Brian de Beaubien, Jude Paganelli, Daniel Pflaster, Daivon Deans, Ryan Watson, Brian Bowman